Cargando…
Low‐dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database
PURPOSE: Low‐dose naltrexone (LDN) is used in a wide range of conditions, including chronic pain and fibromyalgia. Because of the opioid antagonism of naltrexone, LDN users are probably often warned against concomitant use with opioids. In this study, based on data from the Norwegian prescription da...
Autores principales: | Raknes, Guttorm, Småbrekke, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485080/ https://www.ncbi.nlm.nih.gov/pubmed/28370746 http://dx.doi.org/10.1002/pds.4201 |
Ejemplares similares
-
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
por: Raknes, Guttorm, et al.
Publicado: (2018) -
Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
por: Raknes, Guttorm, et al.
Publicado: (2019) -
A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
por: Raknes, Guttorm, et al.
Publicado: (2016) -
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
por: Raknes, Guttorm, et al.
Publicado: (2020) -
Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study
por: Raknes, Guttorm, et al.
Publicado: (2019)